4.8 Article

Common variant at 16p11.2 conferring risk of psychosis

Journal

MOLECULAR PSYCHIATRY
Volume 19, Issue 1, Pages 108-114

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2012.157

Keywords

association; bipolar disorder; cross-disorder; schizophrenia; 16p11.2

Funding

  1. National Institute of Mental Health [N01 MH900001, MH074027, 1U24MH081810, R01 MH078075]
  2. Eli Lilly and Company
  3. Pritzker Neuropsychiatric Disorders Research Fund L.L.C.
  4. Massachusetts General Hospital in Boston, MA (NIMH) [2N01MH080001-001]
  5. Wellcome Trust [076113, 085475, 075491/Z/04, 085475/B/08/Z, 085475/Z/08/Z]
  6. Medical Research Council [G0601030]
  7. Anthony P Monaco, PI, University of Oxford
  8. National Genome Research Network of the German Federal Ministry of Education and Research (BMBF) [01GS08144, 01GS08147]
  9. Centre of Excellence for Complex Disease Genetics of the Academy of Finland [213506, 129680]
  10. Biocentrum Helsinki Foundation
  11. Research Program for Molecular Medicine, Faculty of Medicine, University of Helsinki
  12. Stanley Medical Research Institute
  13. Danish Council for Strategic Research [2101-07-0059]
  14. H Lundbeck A/S
  15. the Research Council of Norway [163070/V50]
  16. Danish Medical Research Council
  17. South-East Norway Health Authority [2004-123]
  18. Medical Research Council
  19. Ministerio de Sanidad y Consumo, Spain [PI081522]
  20. Xunta de Galicia [08CSA005208PR]
  21. Swedish Research Council
  22. Wellcome Trust Case Control Consortium 2
  23. Max Planck Society
  24. Saarland University [T6 03 10 00-45]
  25. Netherlands Foundation for Brain Research (Hersenstichting) [2008(1).34]
  26. [2006-037761]
  27. [PIAP-GA-2008-218251]
  28. [HEALTH-F2-2009-223423]
  29. [HEALTH-F4-2009-242257]
  30. MRC [G1100583, G0801418, G0601030, G0800509] Funding Source: UKRI
  31. British Heart Foundation [PG/13/66/30442] Funding Source: researchfish
  32. Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish
  33. Medical Research Council [G1100583, MR/L010305/1, G0801418, G0801418B, G9817803B, G0800509] Funding Source: researchfish
  34. National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish
  35. NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH900001, U24MH081810, R01MH083094, R01MH078075, N01MH080001, R01MH074027] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Epidemiological and genetic data support the notion that schizophrenia and bipolar disorder share genetic risk factors. In our previous genome-wide association study, meta-analysis and follow-up (totaling as many as 18 206 cases and 42 536 controls), we identified four loci showing genome-wide significant association with schizophrenia. Here we consider a mixed schizophrenia and bipolar disorder (psychosis) phenotype (addition of 7469 bipolar disorder cases, 1535 schizophrenia cases, 333 other psychosis cases, 808 unaffected family members and 46 160 controls). Combined analysis reveals a novel variant at 16p11.2 showing genome-wide significant association (rs4583255[T]; odds ratio = 1.08; P = 6.6 x 10(-11)). The new variant is located within a 593-kb region that substantially increases risk of psychosis when duplicated. In line with the association of the duplication with reduced body mass index (BMI), rs4583255[T] is also associated with lower BMI (P = 0.0039 in the public GIANT consortium data set; P = 0.00047 in 22 651 additional Icelanders).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available